TITLE

CASE FATALITY AND MORBIDITY IN PATIENTS WITH ALCOHOLIC LIVER DISEASE

PUB. DATE
April 2004
SOURCE
Gut;Apr2004 Supplement 3, Vol. 53, pA88
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Alcoholic liver disease (ALD) is a heterogenous condition, in terms of its presentation, clinical course, and mortality. Available data on mortality at the national level show a rising trend in Great Britain in the face of a steady fall in many other European countries. A study was carried out in a district general hospital serving a catchment population of approximately 290 000 and typical of Great britain population. Using 18 categories of ICD10 diagnostic codes for ALD, a total of 211 patients directly related to ALD as a primary diagnosis over a period of 12 months were identified.
ACCESSION #
13219160

 

Related Articles

  • Development and validation of a simple NAFLD clinical scoring system for identifying patients without advanced disease. Harrison, S. A.; Oliver, D.; Arnold, H. L.; Gogia, S.; Neuschwander-Tetri, B. A. // Gut;Oct2008, Vol. 57 Issue 10, p1441 

    Background: Clinical predictors of advanced non-alcoholic liver disease (NAFLD) are needed to guide diagnostic evaluation and treatment. Methods: To better understand the demographics of NAFLD and risk factors for advanced disease, this study analysed 827 patients with NAFLD at two...

  • LIVER IRON GRADE IN DECOMPENSATED ALCOHOLIC LIVER DISEASE: PROGNOSTIC SIGNIFICANCE AND RELATION TO HFE GENOTYPE.  // Gut;Apr2004 Supplement 3, Vol. 53, pA88 

    Moderate liver iron accumulation is common in alcoholic liver disease (ALD). Its causation is poorly understood but it has been associated with a poor outlook. 0, 1, 2, 3, and 4 iron was found in 41, 20, 12, 5, and 0 of the 78 patients respectively. Iron was seen in hepatocytes in 34 patients,...

  • CLINICAL PROFILE OF CASES OF ALCOHOLIC LIVER DISEASE. Suthar, Hemang; Suthar, Kaushal; Mewada, Bhavna // International Journal of Medical Science & Public Health;2013, Vol. 2 Issue 2, p394 

    Background: Alcohol is most common substance abused. Alcoholic liver disease is a major health care problem in India. Alcohol consumption is directly associated with liver disease mortality and accounts for increased social and economic costs. Alcoholic liver disease may take the forms of acute...

  • Alcoholic Hepatitis . Helman, Richard A.; Temko, Michael H.; Nye, Sylvanus W.; Fallon, Harold J. // Annals of Internal Medicine;Mar71, Vol. 74 Issue 3, p311 

    Provides information on a number of patients with acute alcoholic hepatitis documented by liver biopsy during the healing phase. Effect of prednisolone therapy on the course and survival rate of patients with alcoholic hepatitis; Patient grouping for clinical severity of disease; Symptoms and...

  • Liquid assets. Mayer, Chris; Houghton, Graham; Cowell, Roger; Scullion, Jane // Nursing Standard;11/16/2005, Vol. 20 Issue 10, p30 

    Presents letters to the editor regarding readers opinion on liver transplants to an alcoholic patients. "Most People Will Quit If the Alternative Is Death," comments on the negative scenario poses by the message regarding alcoholism; "Patients Must Show a Clear Commitments," focuses on the...

  • Glucocorticoids plus N-Acetylcysteine in Alcoholic Hepatitis.  // New England Journal of Medicine;2/2/2012, Vol. 366 Issue 5, p476 

    The article presents a study on whether combination therapy with glucocorticoids plus N-acetylcysteine would improve the survival of alcoholic hepatitis patients. The researchers assigned 174 patients randomly to receive prednisolone and N-acetylcysteine or only prednisolone. They found that the...

  • Biochemical and Clinical Effects of Aspartame in Patients with Chronic, Stable Alcoholic Liver Disease. Hertelendy, Zsolt I.; Mendenhall, Charles L.; Rouster, Susan D.; Marshall, Laine; Weesner, Robert // American Journal of Gastroenterology;May1993, Vol. 88 Issue 5, p737 

    Aspartame is an artificial sweetener completely metabolized in the gut and absorbed as aspartate, phenylalanine, and methanol. Phenylalanine is thought to mediate or exacerbate hepatic encephalopathy, and an impaired liver may not be able to cope with the ammoniagenic properties of the amino...

  • Should We Use the Model for End-Stage Liver Disease (MELD) to Predict Mortality After Colorectal Surgery? Pantel, Haddon; Stensland, Kristian; Nelson, Jason; Francone, Todd; Roberts, Patricia; Marcello, Peter; Read, Thomas; Ricciardi, Rocco; Pantel, Haddon Jacob; Stensland, Kristian D; Francone, Todd D; Roberts, Patricia L; Marcello, Peter W // Journal of Gastrointestinal Surgery;Aug2016, Vol. 20 Issue 8, p1511 

    We sought to determine the accuracy of the Model for End-Stage Liver Disease and the Mayo Clinic Postoperative Mortality Risk in Patients with Cirrhosis Calculator in patients with ascites who underwent colorectal surgery. The National Surgical Quality Improvement Program database was queried...

  • What's Hot in the Red Journal This Month?  // American Journal of Gastroenterology;Jan2010, Vol. 105 Issue 1, p1 

    The article discusses various reports published within the issue, including one on the study of alcoholic liver disease, one on the correlation of fecal calprotectin with simple endoscopic score for Crohn's disease (SES-CD), and one on the different strategies for screening of colorectal cancer...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sign out of this library

Other Topics